{"entity":{"id":"nct07282587","kind":"trial","name":"Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma","aka":[],"tldr":"A phase 2 trial of ONC206 in pheochromocytoma and paraganglioma, run by Jazz Pharmaceuticals, now recruiting.","summary":"Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma is a phase 2 interventional study registered as NCT07282587 by Jazz Pharmaceuticals, with 90 participants planned, started 2026-01-02 and due to reach its primary completion in 2028-12-15. Interventions recorded: ONC206, ONC206: Dose 1 and ONC206: Dose 2.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07282587","url":"https://clinicaltrials.gov/study/NCT07282587"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["pheochromocytoma-paraganglioma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["jazz"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07282587","phase":"2","setting":"A Phase 2 Study of ONC206 in Advanced Pheochromocytoma and Paraganglioma","sponsor":"Jazz Pharmaceuticals","enrolled":90,"outcomes":[]},"route":"/trials/nct07282587/","neighbours":{"cancer":[{"id":"pheochromocytoma-paraganglioma","kind":"cancer","name":"Pheochromocytoma and paraganglioma (PPGL)","route":"/cancers/pheochromocytoma-paraganglioma/"}],"company":[{"id":"jazz","kind":"company","name":"Jazz Pharmaceuticals","route":"/companies/jazz/"}]}}